AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Altimmune's CEO Vipin Garg will step down on Jan. 1, 2026, after 7 years of leadership. Jerry Durso will succeed him as CEO and Chairman. Durso will retain his current position as Chairman while taking on the new role. Garg will serve as an advisor until June 30, 2026. During his tenure, Altimmune's lead candidate, pemvidutide, progressed from preclinical to clinical stages.
Daily stocks & crypto headlines, free to your inbox
Comments
ο»Ώ
No comments yet